Scripps Expert Discuses Positive Results from COVID-19 Vaccine Clinical Trial

Anil Keswani, MD, co-chairs Scripps effort to evaluate coronavirus vaccines

Two glass vials hold a clear vaccine fluid, next to a syringe.

Anil Keswani, MD, co-chairs Scripps effort to evaluate coronavirus vaccines

Early results from Pfizer’s clinical trial of an mRNA-based coronavirus vaccine are encouraging, but more data is needed to fully evaluate the potential effectiveness of the inoculation, Scripps Health Corporate Senior Vice President and Chief Medical Officer for Ambulatory and Accountable Care Anil Keswani, MD, said in a recent interview with Fox 5 News.


Dr. Keswani also is co-chair of a committee at Scripps that is evaluating all the potential coronavirus vaccines that are undergoing clinical trials.

Media Contact

Keith Darce
858-678-7121
darce.keith@scrippshealth.org
Follow me: @KeithDarce